Page last updated: 2024-10-26

edrophonium and Encephalopathy, Hepatic

edrophonium has been researched along with Encephalopathy, Hepatic in 1 studies

Edrophonium: A rapid-onset, short-acting cholinesterase inhibitor used in cardiac arrhythmias and in the diagnosis of myasthenia gravis. It has also been used as an antidote to curare principles.
edrophonium : A quaternary ammonium ion that is N-ethyl-N,N-dimethylanilinium in which one of the meta positions is substituted by a hydroxy group. It is a reversible inhibitor of cholinesterase, with a rapid onset (30-60 seconds after injection) but a short duration of action (5-15 minutes). The chloride salt is used in myasthenia gravis both diagnostically and to distinguish between under- or over-treatment with other anticholinesterases. It has also been used for the reversal of neuromuscular blockade in anaesthesia, and for the management of poisoning due to tetrodotoxin, a neuromuscular blocking toxin found in puffer fish and other marine animals.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Parkes, JD1
Sharpstone, P1
Williams, R1

Other Studies

1 other study available for edrophonium and Encephalopathy, Hepatic

ArticleYear
Levodopa in hepatic coma.
    Lancet (London, England), 1970, Dec-26, Volume: 2, Issue:7687

    Topics: 5-Hydroxytryptophan; Atropine; Dihydroxyphenylalanine; Edrophonium; Electroencephalography; Epinephr

1970